Evidence map›Paper›PMID 42394497›Full record

ArticleZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2026

[Survey of radiotherapy resource allocation and service capacity in Hunan Province, 2025].

Yunchao Xu, Yujiao Dou, Shixiong Huang, Jingru Yang, Pei Yang, Zhongwei Li, Heikun Jin, Yingzi Li, Gang Huang, Yingrui Shi and 1 more

Abstract readEnglish Abstract
In one paragraph

Article in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yunchao XuDepartment of Radiophysics and Technology, Hunan Cancer Hospital, Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013. yunchao.xu@foxmail.com.
Yujiao DouDepartment of Clinical Nursing, Xiangya Hospital, Central South University, Changsha 410008. 125448900@qq.com.
Shixiong HuangDepartment of Radiophysics and Technology, Hunan Cancer Hospital, Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013.
Jingru YangHunan Provincial Medical Quality Control Center for Cancer Diagnosis and Treatment, Changsha 410013.
Pei YangHunan Provincial Medical Quality Control Center for Cancer Diagnosis and Treatment, Changsha 410013.
Zhongwei LiDepartment of Radiophysics and Technology, Hunan Cancer Hospital, Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013.
Heikun JinHunan Provincial Medical Quality Control Center for Cancer Diagnosis and Treatment, Changsha 410013.
Yingzi LiHunan Provincial Medical Quality Control Center for Cancer Diagnosis and Treatment, Changsha 410013.
Gang HuangHunan Provincial Medical Quality Control Center for Cancer Diagnosis and Treatment, Changsha 410013.
Yingrui ShiHunan Provincial Medical Quality Control Center for Cancer Diagnosis and Treatment, Changsha 410013. shiyingrui@hnca.org.cn.
Biao ZengDepartment of Radiophysics and Technology, Hunan Cancer Hospital, Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013. zengbiao008@163.com.

Funding

the High-Level Talent Support Program of Hunan Cancer Hospital 20250731-1009 and 20250731-1016the Hunan Provincial Health Commission Health Appropriate Technology Promotion Project 202319015975
6 · The paper itself

Abstract

objectivesRadiotherapy is one of the most important treatment modalities for malignant tumors, with 60% to 70% of cancer patients requiring radiotherapy during the course of their disease. This study aims to comprehensively investigate and analyze the current status of radiotherapy in Hunan Province in 2025, providing evidence for optimizing the allocation of radiotherapy resources, enhancing oncology service capacity, and improving the regional radiotherapy system across the province.

methodsBased on the standardized radiation therapy basic information survey form developed by the Hunan Provincial Medical Quality Control Center for Cancer Diagnosis and Treatment, a combined approach of online data submission and offline verification was used to conduct a survey among medical institutions in Hunan Province providing radiation therapy services. Data were collected through a combination of online reporting and on-site verification. Survey items included institutional characteristics, workforce allocation, radiotherapy equipment and auxiliary facilities, implementation of radiotherapy technologies, patient volume, and quality control system development. The survey was conducted from July to September 2025 under the coordination of municipal cancer diagnosis and treatment quality control centers. After data collation and verification, the authenticity of the reported information was further validated through random on-site inspections conducted by the Hunan Provincial Quality Control Center for Cancer Diagnosis and Treatment.

resultsAs of September 2025, Hunan Province had 90 radiotherapy institutions, representing an increase of 14 institutions compared with 2022. Among them, 70 (77.78%) were tertiary hospitals and 74 (82.22%) were public hospitals, which remained the major service providers of radiotherapy services. The proportion of annual radiotherapy patients treated in non-capital-city hospitals increased from 26.5% to 29.3%. A total of 2 057 radiotherapy professionals were employed province-wide, including 889 physicians, 231 medical physicists, 433 radiation therapists, 444 nurses, and 60 engineers, yielding a physician-to-physicist ratio of 3.8꞉1. In terms of equipment, there were 127 external beam radiotherapy units, including 115 medical accelerators (of which 4 were Tomotherapy [TOMO] systems) and 12 Gamma Knife units, as well as 33 brachytherapy afterloading systems. Auxiliary equipment included 85 simulation units, 210 treatment planning systems, 199 dosimeters, and 114 verification systems. Compared with 2022, the numbers of linear accelerators, CT simulators, and dose verification devices increased by 30.59%, 61.54%, and 93.22%, respectively. The province achieved 1.73 linear accelerators per million population, although regional disparities in resource distribution persisted. The proportion of domestically manufactured linear accelerators increased from 10.22% in 2022 to 14.41% in 2025. Regarding radiotherapy technologies, a precision radiotherapy system centered on intensity-modulated radiation therapy (IMRT) had been established, with an IMRT implementation rate of 84.4%. Approximately 45% of radiotherapy institutions had adopted image-guided radiation therapy (IGRT), stereotactic body radiotherapy (SBRT), and respiratory motion management technologies. The annual number of patients receiving radiotherapy across the province reached approximately 48 000. The most common cancer types treated were lung cancer, breast cancer, cervical cancer, nasopharyngeal carcinoma, and rectal cancer, accounting for 60.11% of all radiotherapy cases. Following the implementation of Hunan Medical Insurance Policy [2025] No. 18, precision radiotherapy techniques, including IMRT, volumetric modulated arc therapy (VMAT), TOMO, and SBRT, were incorporated into the Category B reimbursement list of the provincial medical insurance program, substantially improving their accessibility and affordability.

conclusionsThe radiotherapy service capacity of Hunan Province improved substantially in 2025 compared with 2022, as evidenced by increases in the number of radiotherapy institutions and equipment, wider adoption of precision radiotherapy technologies, and further enhancement of quality control systems. A modern precision radiotherapy framework centered on IMRT has been largely established. Optimization of medical insurance reimbursement policies has further improved access to advanced radiotherapy technologies. Nevertheless, challenges remain, including unequal regional distribution of radiotherapy resources, suboptimal utilization efficiency of equipment in primary-level institutions, and shortages of highly qualified medical physicists. Future efforts should focus on strengthening regional coordination and resource allocation, enhancing radiotherapy capacity at the primary care level, improving the standardization of quality control practices, and promoting balanced development of the radiotherapy service system.

Indexed as

Health Care RationingNeoplasmsRadiotherapyResource AllocationChinaHumansRadiation OncologySurveys and QuestionnairesHunan Provinceradiotherapyradiotherapy institutionresource allocationsurvey research

Identifiers

PMID42394497
PMCPMC13305691

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.